Identification of a primary target of thalidomide teratogenicity
- PMID: 20223979
- DOI: 10.1126/science.1177319
Identification of a primary target of thalidomide teratogenicity
Abstract
Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects. Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown. Here, we identified cereblon (CRBN) as a thalidomide-binding protein. CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks. Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity VSports手机版. This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivatives without teratogenic activity. .
Publication types
- "VSports" Actions
MeSH terms
- VSports - Actions
- Actions (V体育ios版)
- V体育平台登录 - Actions
- "V体育ios版" Actions
- V体育ios版 - Actions
- "V体育官网入口" Actions
- Actions (V体育平台登录)
- VSports在线直播 - Actions
- "V体育平台登录" Actions
- "VSports" Actions
- "V体育安卓版" Actions
- V体育平台登录 - Actions
- "VSports最新版本" Actions
"V体育ios版" Substances
- VSports - Actions
- "VSports app下载" Actions
- V体育安卓版 - Actions
- VSports在线直播 - Actions
- "V体育官网入口" Actions
- Actions (VSports在线直播)
- Actions (V体育ios版)
- "VSports注册入口" Actions
- "V体育平台登录" Actions
- "V体育安卓版" Actions
- "VSports注册入口" Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
V体育官网入口 - Research Materials
